We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00841373
Recruitment Status : Completed
First Posted : February 11, 2009
Last Update Posted : November 19, 2014
Genentech, Inc.
Information provided by (Responsible Party):
Mary Savell, Southern New England Retina Associates

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2009
  Study Completion Date : January 2010